Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
eye disease
Biotech
Ray shines a light on $125M round targeting genetic eye therapy
Ray Therapeutics has announced the closing of a $125 million series B financing to support candidates for patients with retinal degeneration.
Will Maddox
Apr 21, 2026 10:33am
J&J hands back failed gene therapy to MeiraGTx
Apr 16, 2026 10:17am
Belite brings FDA filing into view with phase 3 Stargardt win
Dec 1, 2025 8:25am
Lilly bags eye-catching gene therapy in $475M deal
Nov 10, 2025 7:00am
Opus sets sights on FDA talks after posting gene therapy data
Sep 30, 2025 9:15am
Eye disease biotech launches with $100M, Roche rival in clinic
Sep 17, 2025 6:30am